FAQs about Recurrent Pregnancy Loss (RPL)
Miscarriage means a pregnancy that ends naturally on its own. In medical terminology it is often called spontaneous abortion, which does not mean an induced termination. A missed abortion or missed miscarriage means the embryo has stopped developing but there may be no bleeding yet, and this is diagnosed on ultrasound.
A biochemical pregnancy is when the pregnancy test becomes positive but no pregnancy sac is seen on ultrasound and hormone levels fall very early.
Stillbirth refers to pregnancy loss at a later stage, usually after about 20 to 24 weeks depending on the country definition.
Recurrent pregnancy loss is generally defined as two or more failed clinical pregnancies. A clinical pregnancy means one that was confirmed on ultrasound or by examination of pregnancy tissue. Earlier definitions required three losses, but most modern guidelines support evaluation after two.
Most formal definitions of RPL focus on clinical intrauterine pregnancies (meaning pregnancy implanted inside the uterus) confirmed on ultrasound.
Biochemical and ectopic pregnancies are medically important, but they are not always included under classic RPL definitions. However, they are still carefully documented and considered in overall reproductive assessment.
No. The losses do not have to be back to back. Even if there was a successful pregnancy in between, multiple pregnancy losses can still meet criteria for recurrent pregnancy loss.
Recurrent pregnancy loss affects about one to two percent of couples. While individual miscarriages are common, repeated losses are much less frequent.
Most specialists now recommend starting evaluation after two confirmed miscarriages, especially if the woman is older than 35 or if the losses were clinically documented. Waiting for three losses is no longer necessary in many cases.
Yes. Very early losses are most commonly linked to chromosomal issues. Losses in the second trimester raise suspicion for uterine structural problems, cervical weakness, or clotting disorders. The timing helps guide investigation.
Early pregnancy loss refers to a miscarriage that occurs before 13 completed weeks of pregnancy. It is the most common type of miscarriage. Overall, about 10 to 15 percent of clinically recognized pregnancies end in miscarriage, and nearly 80 percent of these losses occur in the first trimester, before 13 weeks.
POC stands for products of conception. It refers to genetic testing of pregnancy tissue after a miscarriage, usually following medical or surgical management. The purpose of POC testing is to determine whether the miscarriage was caused by a chromosomal abnormality in the embryo. It is particularly useful in cases of recurrent pregnancy loss, unexplained miscarriage, or when couples want clarity about the cause of the loss to guide future treatment decisions.
In many cases, it can actually be reassuring. A confirmed chromosomal cause often means the miscarriage was due to a random genetic event rather than a persistent maternal problem. This can improve counseling for future pregnancies.
A typical workup includes assessment of the uterine cavity by ultrasound or hysteroscopy, testing for antiphospholipid syndrome, thyroid function testing, blood sugar evaluation, and sometimes parental karyotyping. The exact plan is individualized.
In up to 30 to 50 percent of couples with recurrent pregnancy loss, all standard investigations return normal results. This situation is referred to as unexplained recurrent pregnancy loss. Despite a normal workup, many of these couples still have a good chance of achieving a successful pregnancy in the future.
No, they are not the same condition.
Recurrent pregnancy loss means that a pregnancy is established, confirmed either by ultrasound or clinical diagnosis, but then ends in miscarriage. The key point is that implantation has already occurred.
Recurrent implantation failure refers to repeated failure to achieve a clinical pregnancy despite transfer of good quality embryos during IVF treatment. In this situation, either implantation does not occur at all, or the pregnancy does not progress to a detectable gestational sac.
In simple terms, recurrent pregnancy loss is a problem of maintaining a pregnancy after it has started, while recurrent implantation failure is a problem of achieving or sustaining implantation in the first place. The evaluation and management strategies for the two conditions are different.
Evaluation is usually recommended after two confirmed miscarriages, particularly if the woman is older than 35 or if the losses were similar in pattern.
Testing too early can lead to unnecessary costs, anxiety, and sometimes treatments that are not evidence based. Investigations should be focused and clinically justified.
Structural problems in the uterus are an important and treatable cause in a subset of women. These include septum, adhesions, large cavity-distorting fibroids, or significant polyps. Proper imaging helps identify these issues.
Some fibroids can increase the risk of miscarriage, but not all of them. Fibroids that grow inside the uterine cavity or press into it are more likely to interfere with pregnancy. Small fibroids that grow outside the cavity usually do not increase miscarriage risk.
Polyps are small growths inside the lining of the uterus. Polyps inside the cavity may affect implantation or early pregnancy stability. In general, polyps larger than about 1 cm are more likely to be significant, and removal is often advised before trying to conceive, especially in women with infertility or recurrent pregnancy loss. Very small polyps may sometimes be monitored instead, depending on the overall situation.
A septate uterus has a partition dividing the uterine cavity. This condition is associated with higher miscarriage rates. It is best diagnosed with 3D ultrasound or hysteroscopy, and surgical correction can improve outcomes in selected cases.
Adenomyosis occurs when endometrial tissue grows into the muscular wall of the uterus. It is more clearly linked with infertility and implantation issues. Its exact role in recurrent miscarriage is still being studied and may vary from patient to patient.
Cervical incompetence usually causes second trimester losses or very early preterm births. In such cases, a cervical stitch called cerclage may be recommended in future pregnancies to reduce risk.
Genetic factors play a role in a minority of couples. Some couples carry balanced chromosomal rearrangements that do not affect their health but can lead to abnormal embryos and miscarriage.
Parental karyotyping is recommended in selected cases, especially when multiple unexplained losses have occurred or when POC testing shows specific chromosomal imbalances. It is not necessary for every couple but can be very important in some.
High resolution karyotyping is a chromosome analysis performed at a higher band level than routine karyotyping. In standard karyotyping, chromosomes are typically analyzed at about 400 to 550 band resolution. High resolution karyotyping studies chromosomes at around 650 to 850 bands, which allows detection of smaller structural changes such as subtle deletions or duplications.
However, even high resolution karyotyping cannot detect very small copy number changes. Modern techniques like chromosomal microarray analysis can identify much smaller genetic gains or losses, often at the kilobase level, making them more sensitive for testing pregnancy tissue after miscarriage.
Yes. Genetic counseling is essential to explain recurrence risk, possible outcomes, and options such as natural conception, IVF with genetic testing, or other strategies.
Not necessarily. If one partner carries a balanced chromosomal rearrangement, such as a balanced translocation, it does not mean that pregnancy is impossible. Many carriers can conceive naturally and go on to have healthy children.
In natural conception, each pregnancy is a matter of chance. Some embryos may inherit a normal or balanced chromosome pattern and develop normally, while others may inherit an unbalanced arrangement and result in miscarriage. The exact risk depends on the specific rearrangement.
IVF with preimplantation genetic testing for structural rearrangements (PGT-SR) does not create better embryos, but it allows selection of embryos that are chromosomally balanced before transfer. This may reduce the risk of repeated miscarriage and shorten the time to a successful pregnancy in some couples, although cumulative live birth rates over time may be similar between natural conception and IVF in certain cases.
The standard tests include lupus anticoagulant, anticardiolipin antibodies, and anti beta-2 glycoprotein I antibodies. These are blood tests and usually need to be repeated after a gap to confirm the diagnosis.
Yes. A diagnosis of APS generally requires persistence of positive antibodies over time. A single positive test is not enough. Repeat testing after about 12 weeks is usually recommended to confirm the condition.
The most effective treatment in pregnancy for confirmed APS is a combination of low-dose aspirin and heparin injections. This approach significantly improves live birth rates in affected women.
In confirmed obstetric APS, aspirin alone is usually not enough. The combination of aspirin and heparin provides better outcomes than aspirin alone.
Low molecular weight heparin is widely used in pregnancy and is considered safe when prescribed appropriately. It does not cross the placenta and does not affect the baby directly. Monitoring and correct dosing are important.
No. Large inherited thrombophilia panels are often overused. In most recurrent miscarriage cases, routine testing for all clotting disorders is not necessary unless there is a personal or family history of thrombosis.
No. Blood thinners should only be used when there is a clear medical indication such as confirmed APS. Using them without evidence can increase risks and does not improve outcomes.
Many immune tests, including NK cell testing, are heavily marketed but lack strong scientific evidence for routine use in recurrent miscarriage. They often lead to expensive treatments without proven benefit.
Progesterone support may be considered in women with previous miscarriages, especially if there is early pregnancy bleeding. However, it is not a universal cure and works best in selected cases.
Vaginal progesterone is commonly used because it acts directly on the uterus and is well tolerated. Injectable forms are used in certain situations. The choice depends on clinical context and physician preference.
Routine aspirin use in women who test negative for APS is not strongly supported by evidence. It should not be taken automatically without a specific indication.
Heparin is not recommended in women who do not have confirmed APS or another clear clotting disorder. Unnecessary anticoagulation can expose patients to bleeding risks.
Steroids are sometimes prescribed for presumed immune causes, but evidence for routine use is limited. They can have side effects and should not be used without clear indication.
These treatments are expensive and not considered standard care for most recurrent miscarriage cases. Evidence supporting their routine use is weak, and they are usually reserved for highly selected or research settings.
Metformin helps improve insulin resistance in PCOS and may improve ovulation and metabolic balance. Its role in preventing miscarriage is not universal and depends on the individual metabolic profile.
Bed rest has not been shown to prevent miscarriage in most cases. In fact, prolonged inactivity can increase stress and other health risks.
No. Light spotting in early pregnancy is common and does not always mean miscarriage. However, any bleeding should be evaluated with appropriate follow-up.
Seeing a heartbeat confirms that it was a clinical pregnancy. A later loss may still be due to chromosomal issues or placental problems. It does not automatically mean there is a persistent underlying condition.
In most cases, couples can try again once physical recovery is complete and bleeding has stopped. Emotional readiness is equally important. There is usually no need to wait many months unless medically advised.
After a D&C, most doctors recommend waiting until at least one normal menstrual cycle has occurred. This allows the uterine lining to recover properly.
Not automatically. Many couples with recurrent pregnancy loss can conceive naturally and go on to have a healthy baby. IVF is considered only when there is a specific indication, such as severe infertility, advanced maternal age, or certain genetic conditions.
IVF by itself does not automatically reduce miscarriage risk. If the underlying issue is age-related chromosomal abnormality, IVF combined with genetic testing may help select chromosomally normal embryos. But IVF alone does not eliminate miscarriage risk.
PGT-A stands for preimplantation genetic testing for aneuploidy. It tests embryos created through IVF to identify those with the correct number of chromosomes. It may reduce the risk of transferring an abnormal embryo, especially in women of advanced age.
Women of advanced maternal age or those with repeated chromosomally abnormal miscarriages may benefit more from PGT-A. It is not equally useful for all couples, especially younger women with unexplained losses.
The chances are still good. Around sixty to seventy percent of couples with two previous miscarriages will go on to have a successful live birth in a future pregnancy, even without major intervention.
Yes, in many cases. This is called secondary recurrent pregnancy loss. Having had a previous live birth often indicates that pregnancy is biologically possible, and the overall chances of future success remain favorable.
The most common cause of early miscarriage is a chromosomal abnormality in the embryo, known as aneuploidy. Around 50 to 70 percent of first trimester miscarriages are due to abnormal chromosome numbers, and the risk increases with maternal age.
Even in recurrent pregnancy loss, embryonic chromosomal abnormalities remain a major cause, particularly in women above 35 years. However, in some couples, especially younger women with repeated losses, other factors such as uterine abnormalities, antiphospholipid syndrome, hormonal imbalance, or parental chromosomal rearrangements may also contribute.
Maternal age is one of the strongest predictors of miscarriage. As age increases, the egg quality declines and chromosomal errors become more frequent, which increases miscarriage risk significantly after age 35.
Advanced paternal age can contribute to miscarriage risk, although its impact is usually smaller than maternal age. Increasing paternal age is associated with higher rates of certain genetic mutations and pregnancy loss.
Aneuploidy means the embryo has an abnormal number of chromosomes. A normal embryo has 46 chromosomes. If there are extra or missing chromosomes, the pregnancy often cannot continue normally, leading to miscarriage.
Tests with strong evidence include uterine cavity assessment, antiphospholipid antibody testing, and thyroid screening. Large thrombophilia panels, routine immune testing, and NK cell testing are often overused without strong supporting evidence.
A practical, cost-effective plan includes uterine cavity evaluation, thyroid testing, blood sugar screening, and antiphospholipid antibody testing. Additional tests are added based on individual history.
Yes, in selected cases both partners should be evaluated, especially if parental chromosomal rearrangement is suspected. Recurrent pregnancy loss is a couple’s issue, not just a female issue.
The most common cause of early miscarriage is chromosomal abnormality in the embryo. This remains true even in many cases of recurrent miscarriage. As maternal age increases, the likelihood of chromosomal errors also rises, making this the leading cause overall.
A euploid embryo has the correct number of chromosomes, which is 46. An aneuploid embryo has extra or missing chromosomes. Most early miscarriages are caused by aneuploid embryos that cannot develop normally.
Women are born with all their eggs. As age increases, the machinery that divides chromosomes inside the egg becomes less accurate. This increases the chance of chromosome separation errors, leading to abnormal embryos and higher miscarriage risk.
Yes, advanced paternal age has been linked to higher miscarriage rates in some studies. The effect is usually smaller than maternal age, but sperm DNA damage and genetic mutations increase gradually with age.
Severe sperm abnormalities can contribute to poor embryo development. However, sperm quality alone is rarely the sole explanation for recurrent miscarriage. It is usually considered alongside other factors.
DNA fragmentation refers to breaks or damage in the genetic material of sperm. High DNA fragmentation index, or DFI, has been associated with poorer reproductive outcomes in some cases. It may contribute to miscarriage risk, but it is not a universal cause and must be interpreted carefully.
Yes. Both untreated hypothyroidism and hyperthyroidism can increase pregnancy complications, including miscarriage. Thyroid levels should be optimized before and during pregnancy.
PCOS mainly affects ovulation and delays conception. However, when associated with obesity or insulin resistance, miscarriage risk may be slightly higher. Managing metabolic health is important.
Poorly controlled diabetes increases miscarriage and congenital anomaly risk. Good blood sugar control before conception significantly improves outcomes.
Significantly elevated prolactin can interfere with ovulation and hormonal balance. While it is not a common cause of recurrent miscarriage, treating abnormal levels is important for overall reproductive health.
Luteal phase deficiency is a controversial diagnosis. It may play a role in some cases, but it is often overdiagnosed. Progesterone support is sometimes used, but it does not solve all recurrent miscarriage cases.
TORCH is an acronym used to describe a group of infections that can affect pregnancy. It stands for:
T – Toxoplasmosis
O – Other infections, commonly including syphilis, varicella and parvovirus
R – Rubella
C – Cytomegalovirus
H – Herpes simplex virus
These infections are more commonly associated with congenital infections and complications during pregnancy rather than recurrent early miscarriage.
Routine TORCH testing is not recommended in the evaluation of recurrent pregnancy loss unless there is a specific clinical suspicion, such as fever, rash, abnormal ultrasound findings, or a history suggesting recent infection. Major guidelines state that indiscriminate TORCH screening does not improve outcomes in recurrent miscarriage cases.
Routine urinary infections, when treated promptly, usually do not cause miscarriage. Severe untreated infections with high fever can increase risk.
Chronic uterine infection is sometimes discussed in infertility contexts, but it is not one of the most common causes of recurrent miscarriage. It should be evaluated based on symptoms and findings, not assumed routinely.
Antiphospholipid syndrome, or APS, is an autoimmune condition in which the body produces antibodies that increase the risk of blood clotting. In pregnancy, these antibodies can interfere with placental development and blood flow, increasing the risk of miscarriage, especially recurrent losses.
No. Even a chromosomally normal embryo can miscarry due to uterine, hormonal, or placental factors. PGT-A reduces one cause of miscarriage but does not eliminate all risks.
PGT-SR is preimplantation genetic testing for structural rearrangements. It is recommended when one partner carries a balanced chromosomal translocation. It helps identify embryos that are genetically balanced before transfer.
In unexplained recurrent pregnancy loss, IVF with PGT-A is not always clearly beneficial. Many couples still achieve natural conception with good outcomes. The decision depends on age, emotional readiness, and financial considerations.
The decision depends on maternal age, number of losses, genetic findings, emotional stress, and time considerations. Younger couples often have good natural prognosis, while older couples may consider IVF with genetic testing to reduce time to pregnancy.
In most cases, couples can try once the body has recovered and bleeding has stopped. Waiting for one normal menstrual cycle is commonly advised but not always mandatory unless medically indicated.
Important steps include optimizing thyroid function, controlling blood sugar, maintaining a healthy weight, taking folic acid, stopping smoking and alcohol, reviewing medications, and ensuring uterine cavity assessment has been done if indicated.
Folic acid is essential. Vitamin D should be corrected if deficient. Iron should be taken if anemia is present. Other supplements should be individualized rather than taken routinely.
Progesterone is often started after ovulation or once pregnancy is confirmed, especially in women with prior early losses or early pregnancy bleeding. The exact timing depends on the clinical plan.
Low-dose aspirin is usually started while trying to conceive or early in pregnancy. Heparin is started once pregnancy is confirmed. Both are continued under medical supervision.
Heparin is usually continued until late pregnancy and stopped close to delivery as per obstetric guidance. Aspirin timing varies but is typically stopped near delivery under supervision.
Monitoring may include early blood tests for pregnancy hormone levels, followed by early ultrasound to confirm location and heartbeat. Follow-up scans are scheduled based on symptoms and prior history.
Heavy bleeding, severe abdominal pain, dizziness, fainting, or high fever require immediate medical attention. Mild spotting without pain is common but should still be reported.
Yes. Smoking increases miscarriage risk and affects placental development. Stopping smoking is one of the most effective lifestyle changes to improve pregnancy outcomes.
Alcohol can increase miscarriage risk, particularly in early pregnancy. The safest recommendation is to avoid alcohol while trying to conceive and during pregnancy.
Moderate caffeine intake, usually under 200 milligrams per day, is considered safe. Excessive caffeine may slightly increase miscarriage risk.
Yes. Obesity is linked to hormonal imbalance, insulin resistance, and inflammation, all of which can affect early pregnancy. Weight optimization improves reproductive outcomes.
Severely low body weight can disrupt hormonal balance and may increase miscarriage risk. A healthy weight range is important for stable pregnancy.
Normal daily stress does not cause miscarriage. Severe uncontrolled medical stress or trauma can affect health, but ordinary emotional stress is not a primary cause of pregnancy loss.
Normal physical activity, travel, climbing stairs, or lifting a toddler does not cause miscarriage in a healthy pregnancy. Most early miscarriages are due to chromosomal abnormalities, not physical movement.
Eating normal amounts of pineapple or ripe papaya does not cause miscarriage. These are common myths not supported by scientific evidence.
In a normal pregnancy without complications, intercourse does not cause miscarriage. It is safe unless specifically advised otherwise by a doctor.
In most cases, no. D&C is generally safe. Rarely, it can cause uterine adhesions, but this is uncommon when performed carefully.
No. Most women who have one miscarriage go on to have a successful pregnancy. Even after recurrent miscarriages, many couples still achieve a healthy live birth with proper evaluation and care.